drugset / Trial / NCT04386915
Study on the Tolerance and Pharmacokinetics of GST-HG141 Tablets
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To Evaluate the Tolerability and Pharmacokinetics of GST-HG141 Tablets in Single-center, Randomized, Double-blind, Placebo-controlled Multiple-dose, Single-dose, Multiple-dose Phase Ia Clinical Trials in Healthy Subjects .
Timeline
- Start
- 2020-05-18
- Primary completion
- 2021-05-30
- Completion
- 2021-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Neracorvir | Other / unclassified | 50 mg | — |
| Subject | Neracorvir | Other / unclassified | 100 mg | — |
| Subject | Neracorvir | Other / unclassified | 200 mg | — |
| Subject | Neracorvir | Other / unclassified | 300 mg | — |
| Subject | Neracorvir | Other / unclassified | 400 mg | — |
| Subject | Neracorvir | Other / unclassified | 500 mg | — |